Company Information
CIN
Status
Date of Incorporation
29 December 1976
State / ROC
Ahmedabad / ROC Ahmedabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
02 August 2023
Paid Up Capital
330,900,000
Authorised Capital
500,000,000
Directors
Sandeep Padmakant Parikh
Director/Designated Partner
over 2 years ago
over 2 years ago
Prashant Premchand Godha
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Shashil Philip Mendonsa
Director/Designated Partner
over 3 years ago
over 3 years ago
Dhara Pratik Shah
Director/Designated Partner
over 4 years ago
over 4 years ago
Piyush Girishchandra Hindia
Manager/Secretary
almost 6 years ago
almost 6 years ago
Nehal Narendra Gandhi
Director/Designated Partner
over 6 years ago
over 6 years ago
Neha Anant Thakore
Director
about 7 years ago
about 7 years ago
Anantha Subramani Iyer
Director
over 16 years ago
over 16 years ago
Narendra Ishwarlal Gandhi
Managing Director
almost 49 years ago
almost 49 years ago
Past Directors
Babu Lal Jain
Additional Director
over 3 years ago
over 3 years ago
Yogesh Babulal Shah
Additional Director
almost 6 years ago
almost 6 years ago
Abhishek Deepak Buddhadev
Nodal Officer
about 6 years ago
about 6 years ago
Atit Nitin Shukla
Director
about 6 years ago
about 6 years ago
Kunal Narendra Gandhi
Additional Director
almost 7 years ago
almost 7 years ago
Ajit Kumar Shantilal Bagadia
Director
almost 10 years ago
almost 10 years ago
Yatin Narendra Shah
Director
almost 10 years ago
almost 10 years ago
Vinod Shridhar Shanbhag
Director
about 13 years ago
about 13 years ago
Dilip Girdharlal Shah
Additional Director
over 17 years ago
over 17 years ago
Shripadraj Upadhyaya
Director
about 19 years ago
about 19 years ago
Shivabettu Somashekara Upadhyaya
Director
almost 21 years ago
almost 21 years ago
Vijay Chandra Shantilal Taksali
Director
over 26 years ago
over 26 years ago
Vinodkant Amritlal Sanghani
Director
about 31 years ago
about 31 years ago
Patents
The present invention discloses a synergistic topical formulation comprising a combination of Alclometasone and Nadifloxacin along with pharmaceutically acceptable excipients for treatment on of dermatoses, acne vulgaris caused by Propionibacterium acne and Staphylococcus species and sycosis vulgaris.
...
Disclosed herein is pharmaceutical composition comprising combination of Etodolac with Paracetamol in a solid dosage form along with the pharmaceutically acceptable excipients useful for the treatment of pain, inflammation in the body caused by osteoarthritis and rheumatoid arthritis.
The present invention discloses a liquid pharmaceutical composition for omprising a therapeutically effective amount of myorelaxant, particularly thiocholchicoside, alongwith pharmaceutically acceptable excipients for oral administration.
The present invention discloses a novel drug delivery system for proton pump inhibitors comprising benzimidazole compounds or their salts,preferably Rabeprazole or its and pharmaceutically acceptable excipients in powder form which is reconstitutable ina parenterally acceptable solvent to form an injectable solution...
The present invention discloses a novel pharmaceutical combination having etoricoxib,
thiocolchicoside and methyl salicylate alongwith pharmaceutically acceptable excipients. The said combination is helpful in alleviating pain and muscular spasms in patients suffering from Osteoarthritis, Rheumatoid Arthritis, soft...
ABSTRACT:
Disclosed herein is the topical pharmaceutical composition comprising combination of Halometasone monohydrate and antifungal drug such as Miconazole nitrate or Clotrimazole along with pharmaceutically acceptable excipients, for treatment of infective eczema and eradicating fungal infections and further it...
Disclosed herein is a Controlled Porosity Osmotic Pump (CPOP) system for water soluble drug such as Trimetazidine dihydrochloride or pharmaceutically acceptable salts thereof, useful for the treatment of angina pectoris. Also disclosed herein is the process for preparation of controlled porosity osmotic pump tablet ...
Disclosed herein, topical composition comprising Alclometasone with Fusidic Acid or its pharmaceutical salt, Sodium Fusidate, along with pharmaceutically acceptable excipient useful for the management of corticosteroid responsive dermatoses, psoriasis, eczema and edema of groin or armpits.
Disclosed herein is a stable sustained release liposomal injection comprising Citicoiine entrapped in the ammonium sulfate liposomes, useful to enhance brain uptake efficiency,
The invention provides a Diacerein oral dispersible tablet formulation comprising diluents, disintegrants, film formers, binders, flavours, sweeteners, lubricants, and/or glidants. The said pharmaceutical formulation is particularly useful for Osteoarthritis.
The present invention describes stable herbal topical compositions comprises volatile oils like Peppermint ka tel (Mentha oil; Oil of Mentha Piperata), Nilgiri ka tel (Eucalyptus oil; Oil of leaves of plant Eucalyptus globulus), Wintergreen oil (Methyl Salicylate or oil extracted from leaves of plant Goultheria Proc...
Disclosed herein is pharmaceutical composition comprising of a COX-II inhibitor and a muscle relaxant in combination which is useful in the treatment of management of pain and pain related disorders and symptoms. Particularly the present invention discloses pharmaceutical composition comprising etoricoxib and tizani...
The present invention discloses a topical formulation for treatment of eczematous reaction comprising a combination of corticosteroid and an anti-fungal agent. Particularly, the present invention discloses a topical formulation comprising a combination of Alclometasone dipropionate and Miconazole nitrate along with ...
The invention disclosed herein is an oral pharmaceutical composition comprising
combination of Etodolac and Thiocolchicoside; along with pharmaceutically acceptable exicipients, and process for preparation thereof.
Disclosed herein is topical composition comprising corticosteroid such as Halobetasol Propionate along with bacteriostatic antibiotic agent such as Fusidic acid or its pharmaceutical salt Sodium fusidate, along with pharmaceutically acceptable excipients in the form of cream and ointment useful for the management of...
Disclosed herein is topical composition comprising therapeutically effective amount
of corticosteroid Halobetasol Propionate and broad-spectrum anti-bacterial agent
Nadifloxacin along with one or more pharmaceutically acceptable excipients for the
treatment of infective dermatoses, infective eczema, atopic der...
Disclosed herein is mouth dissolving pharmaceutical compositions of Rimonabant which comprises Rimonabant in the range of 60 % -10% w/w croscarmellose sodium in the range of 1.5 % -5.0 ww %weight; microcrystalline cellulose (Avicel PH 101/Avicel PH 102) in the range of 10 %-50% w/w; sodium starch glycollate in the r...
Disclosed herin is granular phrmaceutical formulation comprising citicoline, also known as CDP-choline or cytidine diphosphate choline and a physiologically acceptable acidic ingerdiennt along with pharmaceutically acceptable excipients, formulated for despersion in water prior to administration.
...
The present invention discloses an emergency contraceptive formulation for nasal and/or pulmonary administration comprising of levonorgestrel, optionally in combination with ethylestradiol. The said formulation can be in form of solution, suspension or carrier based systems selected from microemulsion and liposomes....
The invention disclosed herein is an oral pharmaceutical composition comprising combination of Citicoline and Vinpocetine along with pharmaceutically acceptable excipients, useful for the treatment of variety of CNS disorders, and process for preparation thereof.
The invention disclosed herein is a topical pharmaceutical composition comprising combination of Sertaconazole nitrate with at least one synthetic corticosteroid selected from Halobetasol propionate or Alclometasone dipropionate along with pharmaceutically acceptable excipients, useful for the effective treatment of...
The invention disclosed herein is a fixed dose pharmaceutical composition comprising combination of Citicoline sodium equivalent to Citicoline and Piracetam along with pharmaceutically acceptable excipients, useful for the treatment of dementia which appears due to senility or Alzheimer"s disease and chronic cerebra...
Disclosed herein are synergistic pharmaceutical parenteral compositions having broad spectrum antibacterial activity comprising combinations of Cephalosporins and Beta-Lactamase inhibitors. More particularly, the invention describes parenteral composition wherein the Cephalosporins are Cefepime, Ceftazidime and Cefo...
The invention discloses a pharmaceutical composition comprising therapeutically effective amount of stimulants, anti-motion drugs and nootropics, either alone or in combination, administered through, oral, intranasal or intravenous, for the treatment and/or management of dyslexia
The controlled released composition comprises Itopride or its pharmaceutically acceptable salts, rate controlling ploymer and one or more pharmaceutically acceptable excipients. Further the invention discloese a process for preparation of controlled relese compositions of Itopride or its pharmaceuticallly acceptable...
The invention discloses a topical anti-inflammatory formulation comprising a myorelaxant in combination with rubefacient and a counter-irritating agent. The invention particularly discloses a topical anti-inflammatory formulation comprising thiocholchicoside, methyl salicylate and menthol in form of gel or ointment ...
The invention disclosed herein is the liquid formulation comprising therapeutically effective amount of Choline Alfoscerate in an amount of 100mg to 500mg /5ml, along with pharmaceutically accepted excipients such as sugar alcohol, co-solvents, flavours, colours and preservatives, wherein said liquid formulation opt...
Disclosed herein is a novel pharmaceutical solid oral dosage form comprising Citicoline and folic acid in a therapeutically effective amount along with pharmaceutically acceptable excipients; useful for the treatment of neurodegenerative disorders. The invention also relates to process for preparation thereof.
...
The present invention discloses a novel pharmaceutical formulation comprising a combination of alclometasone and mupiriocin alongwith pharmaceutically acceptable excipients for treatment of infectious eczematoid dermatitis.
The invention disclosed herein is a topical pharmaceutical composition comprising combination of Halobetasol propionate and Tazarotene along with pharmaceutically acceptable excipients, useful for the treatment of different types of psoriasis and also discloses the process for preparation thereof.
...
A stable topical non-aqueous gel formulation comprising NSAID, particularly Aceclofenac, methyl salicylate and linseed oil useful for the treatment of relief of pain and inflammation associated with acute musculo-skeletal pain in adults like backache, arthritis, strains and sprains etc.
The present invention relates to liquid pharmaceutical composition in the form of palatable syrup for the treatment patients with cerebral injuries of vascular or traumatic origin, memory loss, chronic cerebral vascular insufficiency and degenerative changes in senile dementia. The liquid pharmaceutical composition ...
The present invention discloses a stable microemulsion based topical cream formulation for administration of alclometasone. The said formulation comprises an emollient, an oleaginous vehicle, an emulsifying agent and an oil base as microemulsion forming components alongwith other pharmaceutically acceptable excipien...
The present invention discloses an efficacious topical cream formulation containing halobetasol solubilized in oleaginous vehicle as discontinuous phase, a surfactant or emulsifying agent and an aqueous continuous phase. The said formulation shows improved permeation characteristics
Novel formulation of NSAIDS in liquid or semi solid from for rectal use with drug delivery system wherein the said formulation comprises active ingredient, NSAIDS like refecoxib, paracetamol, nimesulide, valdecoxib and their pharmaceutical analogues; one or more water miscible and non greasy solvents like purified w...
Topical formulation comprising therapeutically effective amount of Etodolac, Methyl Salicylate, and Menthol along with pharmaceutically acceptable excipients in the form of gel and emulgel; useful for relief of pain and inflammation in patients suffering form Osteoarthritis, Rheumatoid arthritis, soft tissue Rheumat...
The present invention discloses a stable microemulsion based topical cream formulation containing Halometasone monohydrate. The said formulation comprises an emollient, an oleaginous vehicle, an emulsifying agent and an oil base as microemulsion forming components alongwith other pharmaceutically acceptable excipien...
The present invention discloses a novel Controlled Porosity Osmotic Release (CPOR) delivery system for controlled release of highly water soluble drugs wherein the controlled porosity of the membrane is accomplished by the use of different channeling agents in varying proportions in the coating solution. The present...
The invention provides Stable compositions comprising Pregabalin wherein the Pregabalin content in the composition is 8%w/w of the total composition and comprises Carbomer (Carbomer Homopolymer Type C) as a gelling agent. The invention additionally provides a process to prepare the stable Pregabalin 8% w/w compositi...
Registered Trademarks
[Class : 5] Pharmaceutical And Medicinal Preparations And Substances
[Class : 5] Pharmaceutical And Medicinal Preparations And Substances
[Class : 5] Veterinary Preparations In The Form Of Injections .
View +74 more Brands for Lyka Labs Limited.
Charges
26 May 2011
Il & Fs Trust Company Limited
20 Crore
05 February 2011
The Kapol Co-operative Bank Ltd.
7 Crore
09 February 2009
Dena Bank
1 Crore
17 September 2007
International Asset Reconstruction Company Private Limited
156 Crore
01 June 2006
Dena Bank
3 Crore
12 August 2005
The Kapol Co-op Bank Ltd
2 Crore
31 March 2005
Dena Bank
2 Crore
25 June 2003
The Kapol Co-op Bank Ltd
1 Crore
17 June 2003
The Kapol Co-op Bank Ltd
1 Crore
11 January 2002
Bank Of Baroda
1 Crore
17 September 2001
Dena Bank
27 Crore
09 July 2001
The Kapol Co-op Bank Ltd
1 Crore
23 February 2001
Bank Of Baroda
99 Lak
27 September 2000
Dena Bank
1 Crore
22 August 2000
The Kapol Co-op Bank Ltd
1 Crore
25 August 1999
Dena Bank
38 Crore
16 April 1999
Dena Bank
14 Crore
26 November 1998
Central Bank Of India
2 Crore
28 November 1996
Uco Bank
9 Crore
06 May 1996
Standard Charterd Bank
50 Lak
15 February 1996
Dena Bank
2 Crore
21 September 1995
Dena Bank
6 Crore
28 July 1995
Dena Bank
50 Crore
28 July 1995
Dena Bank
27 Crore
04 February 1995
Dena Bank
3 Crore
20 December 1994
International Asset Reconstruction Company Private Limited
82 Crore
27 August 1994
Dena Bank
1 Crore
19 July 1994
Dena Bank
15 Crore
22 February 1994
Dena Bank
2 Crore
10 May 1993
Dena Bank
23 Crore
06 May 1993
Dena Bank
7 Lak
22 February 1991
Idbi Bank
13 Lak
18 December 1989
The Industrial Credit And Investment Corporation Of India Lt
10 Lak
01 November 1989
The Icici Ltd
1 Crore
19 June 1989
Bank Of Baroda
30 Lak
27 March 1989
Gujarat Inddustrial Investment Corporation Ltd
31 Lak
13 March 1989
Dena Bank
50 Lak
25 October 1988
Dena Bank
18 Lak
19 May 1988
Dena Bank
43 Lak
04 February 1988
Dena Bank
50 Lak
09 December 1985
Uco Bank
71 Lak
29 November 1985
Dena Bank
10 Lak
20 June 1984
Bank Of Baroda
30 Lak
19 March 1983
Gujarat Industrial Investment Corporation Ltd
60 Lak
06 March 1981
Dena Bank
4 Lak
07 April 1980
Dena Bank
1 Crore
16 November 1978
Dena Bank
15 Lak
30 April 2011
Bank Of Maharashtra
18 Crore
16 September 2005
Futuristic Solutions Limited
25 Crore
25 June 2003
The Kapol Co-op. Bank Ltd
1 Crore
05 May 1999
The Kapol Co-op Bank Ltd
5 Crore
11 June 1999
The Kapol Co-op Bank Ltd
2 Crore
19 April 1994
Bank Of Baroda
1 Crore
25 July 1995
Bank Of Baroda
1 Crore
24 November 2000
Bank Of Baroda
16 Crore
11 November 1992
Bank Of Baroda
1 Lak
15 June 1989
Bank Of Baroda
25 Lak
06 July 1988
Bank Of Baroda
50 Lak
02 December 1994
Bank Of Baroda
6 Lak
08 June 1993
Bank Of Baroda
90 Lak
23 November 1992
Bank Of Baroda
3 Lak
10 August 1989
Bank Of Baroda
75 Lak
06 July 1988
Bank Of Baroda
50 Lak
12 May 1995
Bank Of Baroda
60 Lak
31 December 1985
Bank Of Baroda
1 Crore
28 March 1989
Bank Of Baroda
60 Lak
04 May 1993
Uco Bank
90 Lak
28 February 1996
Uti Bank Ltd
5 Crore
25 August 1995
Uti Bank Ltd
3 Crore
20 November 2019
International Asset Reconstruction Company Private Limited
156 Crore
20 November 2019
International Asset Reconstruction Company Private Limited
156 Crore
03 March 2020
Au Small Finance Bank Limited
2 Crore
05 March 2020
Au Small Finance Bank Limited
2 Crore
24 July 2023
Yes Bank Limited
0
20 November 2019
Others
0
17 September 2007
Others
0
20 November 2019
Others
0
20 December 1994
Others
0
11 June 1999
The Kapol Co-op Bank Ltd
0
05 March 2020
Others
0
16 September 2005
Others
0
31 March 2019
Others
0
03 March 2020
Others
0
05 February 2011
The Kapol Co-operative Bank Ltd.
0
30 April 2011
Bank Of Maharashtra
0
26 May 2011
Il & Fs Trust Company Limited
0
05 May 1999
The Kapol Co-op Bank Ltd
0
16 November 1978
Dena Bank
0
07 April 1980
Dena Bank
0
06 March 1981
Dena Bank
0
20 June 1984
Bank Of Baroda
0
09 December 1985
Uco Bank
0
31 December 1985
Bank Of Baroda
0
04 February 1988
Dena Bank
0
19 May 1988
Dena Bank
0
06 July 1988
Bank Of Baroda
0
28 March 1989
Bank Of Baroda
0
10 August 1989
Bank Of Baroda
0
01 November 1989
The Icici Ltd
0
18 December 1989
The Industrial Credit And Investment Corporation Of India Lt
0
22 February 1991
Idbi Bank
0
23 November 1992
Bank Of Baroda
0
10 May 1993
Dena Bank
0
22 February 1994
Dena Bank
0
27 August 1994
Dena Bank
0
04 February 1995
Dena Bank
0
12 May 1995
Bank Of Baroda
0
21 September 1995
Dena Bank
0
15 February 1996
Dena Bank
0
25 August 1999
Dena Bank
0
22 August 2000
The Kapol Co-op Bank Ltd
0
09 July 2001
The Kapol Co-op Bank Ltd
0
26 November 1998
Central Bank Of India
0
23 February 2001
Bank Of Baroda
0
11 January 2002
Bank Of Baroda
0
01 June 2006
Dena Bank
0
25 June 2003
The Kapol Co-op. Bank Ltd
0
19 April 1994
Bank Of Baroda
0
16 April 1999
Dena Bank
0
17 September 2001
Dena Bank
0
25 June 2003
The Kapol Co-op Bank Ltd
0
19 March 1983
Gujarat Industrial Investment Corporation Ltd
0
29 November 1985
Dena Bank
0
13 March 1989
Dena Bank
0
27 March 1989
Gujarat Inddustrial Investment Corporation Ltd
0
19 June 1989
Bank Of Baroda
0
11 November 1992
Bank Of Baroda
0
04 May 1993
Uco Bank
0
06 May 1993
Dena Bank
0
08 June 1993
Bank Of Baroda
0
19 July 1994
Dena Bank
0
02 December 1994
Bank Of Baroda
0
25 July 1995
Bank Of Baroda
0
28 July 1995
Dena Bank
0
25 August 1995
Uti Bank Ltd
0
28 February 1996
Uti Bank Ltd
0
06 May 1996
Standard Charterd Bank
0
28 November 1996
Uco Bank
0
24 November 2000
Bank Of Baroda
0
17 June 2003
The Kapol Co-op Bank Ltd
0
31 March 2005
Dena Bank
0
12 August 2005
The Kapol Co-op Bank Ltd
0
06 July 1988
Bank Of Baroda
0
25 October 1988
Dena Bank
0
15 June 1989
Bank Of Baroda
0
28 July 1995
Dena Bank
0
27 September 2000
Dena Bank
0
09 February 2009
Dena Bank
0
24 July 2023
Yes Bank Limited
0
20 November 2019
Others
0
17 September 2007
Others
0
20 November 2019
Others
0
20 December 1994
Others
0
11 June 1999
The Kapol Co-op Bank Ltd
0
05 March 2020
Others
0
16 September 2005
Others
0
31 March 2019
Others
0
03 March 2020
Others
0
05 February 2011
The Kapol Co-operative Bank Ltd.
0
30 April 2011
Bank Of Maharashtra
0
26 May 2011
Il & Fs Trust Company Limited
0
05 May 1999
The Kapol Co-op Bank Ltd
0
16 November 1978
Dena Bank
0
07 April 1980
Dena Bank
0
06 March 1981
Dena Bank
0
20 June 1984
Bank Of Baroda
0
09 December 1985
Uco Bank
0
31 December 1985
Bank Of Baroda
0
04 February 1988
Dena Bank
0
19 May 1988
Dena Bank
0
06 July 1988
Bank Of Baroda
0
28 March 1989
Bank Of Baroda
0
10 August 1989
Bank Of Baroda
0
01 November 1989
The Icici Ltd
0
18 December 1989
The Industrial Credit And Investment Corporation Of India Lt
0
22 February 1991
Idbi Bank
0
23 November 1992
Bank Of Baroda
0
10 May 1993
Dena Bank
0
22 February 1994
Dena Bank
0
27 August 1994
Dena Bank
0
04 February 1995
Dena Bank
0
12 May 1995
Bank Of Baroda
0
21 September 1995
Dena Bank
0
15 February 1996
Dena Bank
0
25 August 1999
Dena Bank
0
22 August 2000
The Kapol Co-op Bank Ltd
0
09 July 2001
The Kapol Co-op Bank Ltd
0
26 November 1998
Central Bank Of India
0
23 February 2001
Bank Of Baroda
0
11 January 2002
Bank Of Baroda
0
01 June 2006
Dena Bank
0
25 June 2003
The Kapol Co-op. Bank Ltd
0
19 April 1994
Bank Of Baroda
0
16 April 1999
Dena Bank
0
17 September 2001
Dena Bank
0
25 June 2003
The Kapol Co-op Bank Ltd
0
19 March 1983
Gujarat Industrial Investment Corporation Ltd
0
29 November 1985
Dena Bank
0
13 March 1989
Dena Bank
0
27 March 1989
Gujarat Inddustrial Investment Corporation Ltd
0
19 June 1989
Bank Of Baroda
0
11 November 1992
Bank Of Baroda
0
04 May 1993
Uco Bank
0
06 May 1993
Dena Bank
0
08 June 1993
Bank Of Baroda
0
19 July 1994
Dena Bank
0
02 December 1994
Bank Of Baroda
0
25 July 1995
Bank Of Baroda
0
28 July 1995
Dena Bank
0
25 August 1995
Uti Bank Ltd
0
28 February 1996
Uti Bank Ltd
0
06 May 1996
Standard Charterd Bank
0
28 November 1996
Uco Bank
0
24 November 2000
Bank Of Baroda
0
17 June 2003
The Kapol Co-op Bank Ltd
0
31 March 2005
Dena Bank
0
12 August 2005
The Kapol Co-op Bank Ltd
0
06 July 1988
Bank Of Baroda
0
25 October 1988
Dena Bank
0
15 June 1989
Bank Of Baroda
0
28 July 1995
Dena Bank
0
27 September 2000
Dena Bank
0
09 February 2009
Dena Bank
0
Documents
Form MGT-7-09012021_signed
Form MGT-7-10022021_signed
Form AOC-4(XBRL)-01012021-signed
Approval letter for extension of AGM;-31122020
Copy of MGT-8-31122020
List of share holders, debenture holders;-31122020
Optional Attachment-(2)-31122020
Optional Attachment-(1)-31122020
XBRL document in respect Consolidated financial statement-30122020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-30122020
Form INC-28-11122020-signed
Optional Attachment-(2)-27112020
Optional Attachment-(5)-27112020
Copy of court order or NCLT or CLB or order by any other competent authority.-27112020
Optional Attachment-(1)-27112020
Optional Attachment-(3)-27112020
Optional Attachment-(4)-27112020
Optional Attachment-(3)-13112020
Optional Attachment-(1)-13112020
Copy of court order or NCLT or CLB or order by any other competent authority.-13112020
Optional Attachment-(2)-13112020
Form MR-1-14102020_signed
Copy of shareholders resolution-14102020
Copy of letter of consent to act as Managing Director/ Whole time Director/Manager ; -14102020
Copy of board resolution-14102020
Optional Attachment-(1)-13102020
Form DIR-12-13102020_signed
Form MGT-15-09102020_signed
Form MGT-14-09102020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-08102020
